Showing posts with label Guidance Lay Out FDA Enforcement On Drug Supply Chain. Show all posts
Showing posts with label Guidance Lay Out FDA Enforcement On Drug Supply Chain. Show all posts

Sunday, July 21, 2013

From Inside Health Policy July 22, 2013 Proposed Rule, Guidance Lay Out FDA Enforcement On Drug Supply Chain

FDA is taking steps to institute a drug supply chain enforcement plan under which the agency would detain drugs it believes are adulterated as well as penalize manufacturers that do not comply with agency inspectors, issuing a proposed rule and draft guidance July 12 . . .